HOT NEWS
European Commission Issues Positive Decision for Approval of Seroquel XR » AstraZeneca announced that the European Commission (EC) has issued a positive decision for the appro...
Data from Mipomersen Phase 3 Trial in heFH Patients Presented at ESC » Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced that data from t...
Global market launch of Daxas® (Roflumilast) kicks off in Germany » Stefan Brinkmann, Managing Director of Nycomed GmbH, kicked off the German market launch of Daxas® ...
A new era for patients with atrial fibrillation - Dabigatran etexilate at the fo... » The European Society of Cardiology (ESC) issued revised practice guidelines for the management of at...
Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILIN... » A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that th...
Shire Announces European Approval of VPRIV® (velaglucerase alfa) » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced today...
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial ... » Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from...
GSK European Commission amends licence for Cervarix® » GlaxoSmithKline (GSK) confirmed that the European Commission has granted Marketing Authorisation to ...
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial » Amgen (Nasdaq: AMGN) announced top-line results from a randomized Phase 3 trial evaluating Vectibix(...
Pfizer Reports Second-Quarter 2010 Results » Pfizer Inc. (NYSE: PFE) has reported financial results for second-quarter 2010. Since the acquisitio...
Abbott
AbbottAbbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries. For more information, please visit http://www.abbott.com

Abbott RSS Channel
Title Filter     Display # 
# Article Title Hits
1 Abbott Announces European Launch of TREK(TM) Catheter System 906
2 Abbott Honored as a Great Place to Work Across Europe 911
3 Abbott Completes Acquisition of Solvay Pharmaceuticals 1362
4 Monoclonal Antibody Adds Early-Stage Biologic to Abbott's Oncology Pipeline 1489
5 Abbott's XIENCE PRIME™ and XIENCE V® Receive Indications in Europe for Treatment of Patients with Diabetes 1521
6 Abbott to Acquire Solvay Pharmaceuticals Business 1625
7 Abbott to Acquire Visiogen, Expanding Vision Care Portfolio 1057
8 Abbott Reports Strong Second Quarter Results 1036
9 Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent 1230
10 Abbott's XIENCE V(R) Demonstrates Impressive Results in SPIRIT V Study 1471
11 New data to be presented on Abbott's market-leading XIENCE V(R) stent 817
12 Abbott Reports 16 Percent Earnings Growth in First Quarter 650
13 New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium 1583
14 The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent 979
15 Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics 652
16 Abbott Receives EC Clearance on Acquisition of Advanced Medical Optics 711
17 Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter 778
18 Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection 855
19 Abbott Announces Earnings Guidance for 2009 556
20 Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen 664
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share